Lawyers from all over the U.S. are participating in another of several baby powder trials in St. Louis. The baby powder cancer lawsuit alleges the plaintiff developed ovarian cancer as a result of using Johnson & Johnson’s talc-based baby powder and Shower-to-Shower powder.

Both of these products are popularly used for personal hygiene, with numerous women applying the powders to their genital area to reduce smell, moisture and friction. However it is this very use that, many claim, has resulted in thousands of women developing ovarian cancer.

There are currently thousands of baby powder cancer lawsuits pending in state and federal courts so specialized lawyers are monitoring this particular baby powder trial to see the outcome. More specifically, these lawyers are looking to see if Johnson & Johnson can prevail in a second victory in a baby powder cancer lawsuit.

Prior to the company’s previous legal victory, Johnson & Johnson experienced three consecutive losses in baby powder cancer lawsuits. Each of these trials concluded in Judge Rex Burlison’s courtroom in St. Louis, Missouri.

These plaintiff victories totaled up to $200 million in damages which were awarded to women who had reportedly developed ovarian cancer as a result of using the company’s talc based powders.

Current and past plaintiffs name Johnson & Johnson and talc supplying company, Imerys Talc America, of failing to disclose the alleged association between talc and heightened risk of certain cancers.

Overview of Baby Powder Trial

The current baby powder trial is centered around Lois S., a 61 year old Virginia woman alleging she developed ovarian cancer because she used Johnson & Johnson Baby Powder and Shower-to-Shower on her genital area.

It is important to note that Lois’ case reportedly was selected for the baby powder trial by Johnson & Johnson and Imerys, because the case being was favorable to them.

The baby powder trial was originally set to be a plaintiff selection after Johnson & Johnson had the previous choice in March, but Lois’s worsening health required a quicker trial date.

However, Lois’s attorney stated jurors would see internal documents from Johnson & Johnson during the baby powder trial which will show a clear link between talc and ovarian powder going back 30 years. These documents also show the company took strong measure to insure talc was not classified as a carcinogen.

Depending on the outcome of this baby powder trial hearing in June, a bellwether trial is scheduled for July 2017. The verdict in this baby powder trial may influence potential settlement negotiations in other talc powder cancer lawsuits.

This Baby Powder Cancer Lawsuit is Case No. 1422 CC09326-01 in Missouri’s 22nd Judicial Circuit Court.